Selective autophagy as a potential therapeutic target for neurodegenerative disorders

Aurora Scrivo, Mathieu Bourdenx, Olatz Pampliega, Ana Maria Cuervo

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Cells rely on surveillance systems such as autophagy to handle protein alterations and organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular mechanism for degradation of intracellular components in lysosomes, frequently leads to neurodegeneration. The neuroprotective effect of autophagy stems from its ability to eliminate pathogenic forms of proteins such as α-synuclein or tau. However, the same pathogenic proteins often affect different types and steps of the autophagic process. Furthermore, genetic studies have shown that some proteins related to neurodegeneration, such as huntingtin, participate in autophagy as one of their physiological functions. This complex interplay between autophagy and neurodegeneration suggests that targeting autophagy as a whole might have limited applicability in neurodegenerative diseases, and that future efforts should focus instead on targeting specific types and steps of the autophagic process. This change of strategy in the modulation of autophagy might hold promise for future disease-modifying therapies for patients with neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)802-815
Number of pages14
JournalThe Lancet Neurology
Volume17
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Autophagy
Neurodegenerative Diseases
Therapeutics
Proteins
Synucleins
Neuroprotective Agents
Lysosomes
Organelles

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Selective autophagy as a potential therapeutic target for neurodegenerative disorders. / Scrivo, Aurora; Bourdenx, Mathieu; Pampliega, Olatz; Cuervo, Ana Maria.

In: The Lancet Neurology, Vol. 17, No. 9, 01.09.2018, p. 802-815.

Research output: Contribution to journalReview article

Scrivo, Aurora ; Bourdenx, Mathieu ; Pampliega, Olatz ; Cuervo, Ana Maria. / Selective autophagy as a potential therapeutic target for neurodegenerative disorders. In: The Lancet Neurology. 2018 ; Vol. 17, No. 9. pp. 802-815.
@article{d11bf1d6e6cb43a7b7ccf07f25074493,
title = "Selective autophagy as a potential therapeutic target for neurodegenerative disorders",
abstract = "Cells rely on surveillance systems such as autophagy to handle protein alterations and organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular mechanism for degradation of intracellular components in lysosomes, frequently leads to neurodegeneration. The neuroprotective effect of autophagy stems from its ability to eliminate pathogenic forms of proteins such as α-synuclein or tau. However, the same pathogenic proteins often affect different types and steps of the autophagic process. Furthermore, genetic studies have shown that some proteins related to neurodegeneration, such as huntingtin, participate in autophagy as one of their physiological functions. This complex interplay between autophagy and neurodegeneration suggests that targeting autophagy as a whole might have limited applicability in neurodegenerative diseases, and that future efforts should focus instead on targeting specific types and steps of the autophagic process. This change of strategy in the modulation of autophagy might hold promise for future disease-modifying therapies for patients with neurodegenerative disorders.",
author = "Aurora Scrivo and Mathieu Bourdenx and Olatz Pampliega and Cuervo, {Ana Maria}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/S1474-4422(18)30238-2",
language = "English (US)",
volume = "17",
pages = "802--815",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "9",

}

TY - JOUR

T1 - Selective autophagy as a potential therapeutic target for neurodegenerative disorders

AU - Scrivo, Aurora

AU - Bourdenx, Mathieu

AU - Pampliega, Olatz

AU - Cuervo, Ana Maria

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Cells rely on surveillance systems such as autophagy to handle protein alterations and organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular mechanism for degradation of intracellular components in lysosomes, frequently leads to neurodegeneration. The neuroprotective effect of autophagy stems from its ability to eliminate pathogenic forms of proteins such as α-synuclein or tau. However, the same pathogenic proteins often affect different types and steps of the autophagic process. Furthermore, genetic studies have shown that some proteins related to neurodegeneration, such as huntingtin, participate in autophagy as one of their physiological functions. This complex interplay between autophagy and neurodegeneration suggests that targeting autophagy as a whole might have limited applicability in neurodegenerative diseases, and that future efforts should focus instead on targeting specific types and steps of the autophagic process. This change of strategy in the modulation of autophagy might hold promise for future disease-modifying therapies for patients with neurodegenerative disorders.

AB - Cells rely on surveillance systems such as autophagy to handle protein alterations and organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular mechanism for degradation of intracellular components in lysosomes, frequently leads to neurodegeneration. The neuroprotective effect of autophagy stems from its ability to eliminate pathogenic forms of proteins such as α-synuclein or tau. However, the same pathogenic proteins often affect different types and steps of the autophagic process. Furthermore, genetic studies have shown that some proteins related to neurodegeneration, such as huntingtin, participate in autophagy as one of their physiological functions. This complex interplay between autophagy and neurodegeneration suggests that targeting autophagy as a whole might have limited applicability in neurodegenerative diseases, and that future efforts should focus instead on targeting specific types and steps of the autophagic process. This change of strategy in the modulation of autophagy might hold promise for future disease-modifying therapies for patients with neurodegenerative disorders.

UR - http://www.scopus.com/inward/record.url?scp=85051401018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051401018&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(18)30238-2

DO - 10.1016/S1474-4422(18)30238-2

M3 - Review article

C2 - 30129476

AN - SCOPUS:85051401018

VL - 17

SP - 802

EP - 815

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 9

ER -